BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12459888)

  • 1. Relation between cholesterol levels, statins and Alzheimer's disease in the human population.
    Austen B; Christodoulou G; Terry JE
    J Nutr Health Aging; 2002; 6(6):377-82. PubMed ID: 12459888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.
    Pregelj P
    Psychiatr Danub; 2008 Jun; 20(2):162-7. PubMed ID: 18587285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of statins in Alzheimer's disease.
    Kandiah N; Feldman HH
    J Neurol Sci; 2009 Aug; 283(1-2):230-4. PubMed ID: 19321181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do statins slow down Alzheimer's disease? A review.
    Caballero J; Nahata M
    J Clin Pharm Ther; 2004 Jun; 29(3):209-13. PubMed ID: 15153082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol and Alzheimer's disease--is there a relation?
    Sjögren M; Mielke M; Gustafson D; Zandi P; Skoog I
    Mech Ageing Dev; 2006 Feb; 127(2):138-47. PubMed ID: 16332384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders.
    Itzhaki RF; Wozniak MA
    Prog Lipid Res; 2006 Jan; 45(1):73-90. PubMed ID: 16406033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis.
    Zhou B; Teramukai S; Fukushima M
    Dement Geriatr Cogn Disord; 2007; 23(3):194-201. PubMed ID: 17259710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease?
    Michikawa M
    J Neurosci Res; 2003 Apr; 72(2):141-6. PubMed ID: 12671988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins: the role in the treatment and prevention of Alzheimer's neurodegeneration.
    Pac-Soo C; Lloyd DG; Vizcaychipi MP; Ma D
    J Alzheimers Dis; 2011; 27(1):1-10. PubMed ID: 21734347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain cholesterol, statins and Alzheimer's Disease.
    Kirsch C; Eckert GP; Koudinov AR; Müller WE
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S113-9. PubMed ID: 14574624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cholesterol and statins in Alzheimer's disease.
    Miller LJ; Chacko R
    Ann Pharmacother; 2004 Jan; 38(1):91-8. PubMed ID: 14742802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.
    Zandi PP; Sparks DL; Khachaturian AS; Tschanz J; Norton M; Steinberg M; Welsh-Bohmer KA; Breitner JC;
    Arch Gen Psychiatry; 2005 Feb; 62(2):217-24. PubMed ID: 15699299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol-modifying strategies for Alzheimer's disease.
    Solomon A; Kivipelto M
    Expert Rev Neurother; 2009 May; 9(5):695-709. PubMed ID: 19402779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease.
    Reiss AB; Siller KA; Rahman MM; Chan ES; Ghiso J; de Leon MJ
    Neurobiol Aging; 2004 Sep; 25(8):977-89. PubMed ID: 15212822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?
    Ledesma MD; Dotti CG
    FEBS Lett; 2006 Oct; 580(23):5525-32. PubMed ID: 16814780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.
    Wolozin B; Manger J; Bryant R; Cordy J; Green RC; McKee A
    Acta Neurol Scand Suppl; 2006; 185():63-70. PubMed ID: 16866913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects.
    Sala SG; Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
    J Pharmacol Exp Ther; 2008 Jan; 324(1):352-9. PubMed ID: 17928568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease.
    Panza F; Capurso C; D'Introno A; Colacicco AM; De Candia D; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2007 Jan; 55(1):133-5. PubMed ID: 17233704
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
    Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
    Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1.
    Hill JM; Steiner I; Matthews KE; Trahan SG; Foster TP; Ball MJ
    Med Hypotheses; 2005; 64(1):53-8. PubMed ID: 15533611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.